This inventor holds 1 USPTO granted patent. Top assignee: Chengda Pharmaceuticals Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Junkui Dang in Pharmaceutical Synthesis
Introduction
Junkui Dang is a notable inventor based in Gansu, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative methods for creating chemical compounds. His work is essential for the development of pharmaceutical intermediates and organic chemical intermediates.
Latest Patents
Junkui Dang holds a patent for a method for synthesizing 1,7-naphthyridine derivatives. This invention discloses a systematic approach that includes several key steps. The method begins with using 2-chloro-3-amino-pyridine as Compound I, which is then protected to prepare Compound II. Following this, Compound II reacts with an aldehydation reagent under alkaline conditions to yield Compound III. Finally, Compound III is cyclized with acrylate compounds in the presence of a Lewis acid to produce Compound IV. This innovative process enhances the efficiency of synthesizing important pharmaceutical compounds.
Career Highlights
Junkui Dang is currently associated with Chengda Pharmaceuticals Co., Ltd., where he applies his expertise in chemical synthesis. His work at the company has been instrumental in advancing the development of new pharmaceutical products. With a focus on innovation, he continues to contribute to the field through his research and development efforts.
Collaborations
Junkui Dang collaborates with Huafei Shen, a fellow researcher in the field. Their partnership has fostered a productive environment for innovation and development in pharmaceutical synthesis.
Conclusion
Junkui Dang's contributions to the field of pharmaceutical synthesis through his innovative methods are noteworthy. His patent for synthesizing 1,7-naphthyridine derivatives exemplifies his commitment to advancing chemical synthesis techniques. Through his work at Chengda Pharmaceuticals Co., Ltd., he continues to make significant strides in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile